HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 2,162.131 million compared to CNY 1,874.478 million a year ago. Operating income was CNY 54.991 million compared to CNY 64.730 million a year ago. Net income was CNY 40.015 million compared to CNY 48.296 million a year ago. Basic earnings per share from continuing operations was CNY 0.069 compared to CNY 0.0833 a year ago.